Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
<p>Modifications to vaccine delivery that increase serum antibody longevity are of great interest for maximizing efficacy. We have previously shown that a delayed fractional (DFx) dosing schedule (0-1-6 month) — using AS01<sub>B</sub>-adjuvanted RH5.1 malaria antigen &...
Үндсэн зохиолчид: | Nielsen, CM, Barrett, JR, Davis, C, Fallon, JK, Goh, C, Michell, AR, Griffin, C, Kwok, A, Loos, C, Darko, S, Laboune, F, Tekman, M, Diouf, A, Miura, K, Francica, JR, Ransier, A, Long, CA, Silk, SE, Payne, RO, Minassian, AM, Lauffenburger, DA, Seder, RA, Douek, DC, Alter, G, Draper, SJ |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
American Society for Clinical Investigation
2023
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
-н: Carolyn M. Nielsen, зэрэг
Хэвлэсэн: (2023-01-01) -
Efficacy of the novel Plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial
-н: Minassian, A, зэрэг
Хэвлэсэн: (2018) -
Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies
-н: Miura, K, зэрэг
Хэвлэсэн: (2023) -
HLA-B51 IN BEHÇET’S DISEASE
-н: F Davatchi, зэрэг
Хэвлэсэн: (2008-12-01) -
HLA-B51 IN BEHÇET’S DISEASE
-н: F Davatchi, зэрэг
Хэвлэсэн: (2008-12-01)